William C. Buss

413 total citations
26 papers, 303 citations indexed

About

William C. Buss is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Clinical Biochemistry. According to data from OpenAlex, William C. Buss has authored 26 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Clinical Biochemistry. Recurrent topics in William C. Buss's work include Signaling Pathways in Disease (6 papers), Metabolism and Genetic Disorders (4 papers) and Renal Transplantation Outcomes and Treatments (3 papers). William C. Buss is often cited by papers focused on Signaling Pathways in Disease (6 papers), Metabolism and Genetic Disorders (4 papers) and Renal Transplantation Outcomes and Treatments (3 papers). William C. Buss collaborates with scholars based in United States. William C. Buss's co-authors include William M. Bennett, Donald C. Houghton, Seymour Alpert, Diana Gonzales‐Pacheco, William F. Woodside, Kathleen M. Koehler, David N. Gilbert, Ernest Kun, Sally A. Little and William M. Bennett and has published in prestigious journals such as Science, Biochemistry and Journal of the American Society of Nephrology.

In The Last Decade

William C. Buss

26 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William C. Buss United States 11 113 50 39 35 34 26 303
Malinee Sastrasinh United States 8 242 2.1× 194 3.9× 94 2.4× 104 3.0× 54 1.6× 14 607
Chao‐Min Hoe United States 11 132 1.2× 76 1.5× 34 0.9× 13 0.4× 13 0.4× 15 480
Albert Cohen United States 11 44 0.4× 83 1.7× 30 0.8× 17 0.5× 36 1.1× 14 312
Joseph P. Dewulf Belgium 10 169 1.5× 47 0.9× 17 0.4× 23 0.7× 6 0.2× 27 374
Rosanne K. Fidelus United States 9 194 1.7× 26 0.5× 7 0.2× 29 0.8× 10 0.3× 12 387
Marie‐Louise Part Switzerland 6 242 2.1× 97 1.9× 49 1.3× 8 0.2× 3 0.1× 7 373
Jin Shimakura Japan 7 148 1.3× 51 1.0× 83 2.1× 184 5.3× 30 0.9× 11 397
Madelyn M. Caltabiano United States 8 215 1.9× 68 1.4× 14 0.4× 23 0.7× 6 0.2× 13 346
M. D. Yago Spain 11 43 0.4× 80 1.6× 20 0.5× 14 0.4× 11 0.3× 32 338

Countries citing papers authored by William C. Buss

Since Specialization
Citations

This map shows the geographic impact of William C. Buss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William C. Buss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William C. Buss more than expected).

Fields of papers citing papers by William C. Buss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William C. Buss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William C. Buss. The network helps show where William C. Buss may publish in the future.

Co-authorship network of co-authors of William C. Buss

This figure shows the co-authorship network connecting the top 25 collaborators of William C. Buss. A scholar is included among the top collaborators of William C. Buss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William C. Buss. William C. Buss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Buss, William C. & Larry D. Bowers. (1995). The dose-dependent inhibition of rat renal translation elongation seen after in vivo cyclosporin A is not caused by cyclosporin metabolites. Toxicology. 100(1-3). 17–25. 3 indexed citations
3.
Buss, William C., et al.. (1994). Association of tissue-specific changes in translation elongation after cyclosporin with changes in elongation factor 2 phosphorylation. Biochemical Pharmacology. 48(7). 1459–1469. 10 indexed citations
4.
Ruı́z-Cabello, Jesús, et al.. (1994). Changes in ATP after cyclosporin A treatment in a renal epithelial cell line in the rat studied by 31P-NMR spectroscopy.. PubMed. 86(1). 3–13. 7 indexed citations
5.
Buss, William C., et al.. (1993). Characterization of the inhibition of renal translation in the Sprague-Dawley rat following in vivo cyclosporin A. International Journal of Immunopharmacology. 15(1). 63–76. 7 indexed citations
6.
Buss, William C., et al.. (1993). Tissue specificity of translation inhibition in Sprague-Dawley rats following in vivo cyclosporin A. International Journal of Immunopharmacology. 15(6). 775–782. 5 indexed citations
7.
Gonzales‐Pacheco, Diana, William C. Buss, Kathleen M. Koehler, William F. Woodside, & Seymour Alpert. (1993). Energy Restriction Reduces Metabolic Rate in Adult Male Fisher-344 Rats. Journal of Nutrition. 123(1). 90–97. 58 indexed citations
8.
Buss, William C. & Richard H. Griffey. (1991). Dissociation of decreases in renal cellular energetics and recovery of renal microsomal translation during chronic cyclosporine a administration. Biochemical Pharmacology. 42(1). 71–76. 5 indexed citations
9.
Bennett, William M., Jessie N. Lindsley, & William C. Buss. (1991). THE EFFECTS OF AGE AND DOSAGE ROUTE ON EXPERIMENTAL CYCLOSPORINE NEPHROTOXICITY. Transplantation. 51(3). 730–730. 11 indexed citations
10.
Buss, William C., et al.. (1989). A new proposal for the mechanism of cyclosporine a nephrotoxicity. Inhibition of renal microsomal protein chain elongation following in vivo cyclosporine a. Biochemical Pharmacology. 38(22). 4085–4093. 16 indexed citations
11.
Buss, William C., et al.. (1988). Effect of calcium channel antagonists on calcium uptake and release by isolated rat cardiac mitochondria. European Journal of Pharmacology. 152(3). 247–253. 23 indexed citations
12.
Bennett, William M., et al.. (1988). Microsomal protein synthesis inhibition: an early manifestation of gentamicin nephrotoxicity. American Journal of Physiology-Renal Physiology. 255(2). F265–F269. 41 indexed citations
13.
Buss, William C., et al.. (1987). Coordinate increases and decreases in mitochondrial RNA and ATP syntheses produced by propranolol and rifampicin. Biochemical Pharmacology. 36(19). 3293–3297. 6 indexed citations
14.
Buss, William C., et al.. (1986). Toxic overdose of isoniazid, rifampicin and ethambutol. European Journal of Clinical Pharmacology. 30(3). 381–382. 4 indexed citations
15.
Buss, William C., et al.. (1985). Gentamicin administered in vivo reduces protein synthesis in microsomes subsequently isolated from rat kidneys but not from rat brains. Journal of Antimicrobial Chemotherapy. 15(6). 715–721. 16 indexed citations
17.
Buss, William C.. (1979). Induction of hepatic drag metabolizing enzymes and pregnancy while taking oral contraceptives. Journal of Antimicrobial Chemotherapy. 5(1). 4–5. 2 indexed citations
18.
Buss, William C., et al.. (1978). Rifampicin Inhibition of Protein Synthesis in Mammalian Cells. Science. 200(4340). 432–434. 21 indexed citations
19.
Buss, William C. & John D. Gabourel. (1973). Cortisol effect on protein synthesis and ribonucleic acid polymerase activity in rat thymus. Biochemical Pharmacology. 22(13). 1565–1572. 2 indexed citations
20.
Buss, William C.. (1971). Cortisol effect on protein synthesis and RNA polymerase activity in rat thymus. OHSU Digital Commons. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026